Email Alert | RSS    帮助

中国防痨杂志 ›› 2001, Vol. 23 ›› Issue (3): 184-186.

• 论著 • 上一篇    下一篇

胸腔内灌注母牛分支杆菌疫苗治疗癌性胸液

卢水华1;汪自然1;王汉香1;熊昌富2;王彦君1;朱庭菊1;顾晓洪1;徐学文1;   

  1. 1.武汉铁路结核病防治院 武汉 430083; 2..湖北省医学科学院结防所 武汉 430083;
  • 出版日期:2001-03-10 发布日期:2001-11-03

Clinical observation of intrapleural injection of Mycobacterium vaccae vaccine for patients with malignant pleural effusion

LU Shui-hua,WANG Zi-ran,WANG Han-xiang,et al.   

  1. Wuhan railway Tuberculosis Hospital,Wuhan 430083
  • Online:2001-03-10 Published:2001-11-03

摘要: 目的 探索母牛分支杆菌疫苗在治疗癌性胸液中的作用。方法 肺癌并癌性胸液40例,配对随机分组,治疗组胸腔内灌注母牛分支杆菌疫苗1000μg2~3次,对照组胸腔内灌注顺铂40~60mg2~3次,两组均同时给以全身化疗。结果 治疗组完全有效率60%(12/20)明显高于对照组20%(4/20),治疗组的有效率90%(18/20)亦高于对照组的55%(11/20),P<0.05。结论 母牛分支杆菌疫苗可用于癌性胸液的局部治疗。

关键词: 母牛分支杆菌, 胸腔积液, 肺癌, 免疫治疗

Abstract: Objective To determine the effects of intrapleural injection of Mycobacterium vaccae vaccine for patients with lung cancer and pleural effusion. Methods 40 patients with lung cancer and malignant pleural effusion were divided into study group and control group at random pair.Mycobacterium vaccae vaccine 1000μg were injected into the pleural cavity once weekly for 2~3 weeks for the control group. Results 90%(18/20) of the study group achieved partial relief and 60%(12/20) had complete relief. Both of which were significant higher than those of the control group(P<0.05),while 55%(11/20) of the control group achieved partial relief and 20%(4/20) had complete relief,after 1yr follow-up,the relapse rat of pleural effusion of the study group was 5%(1/18),and the control group was 46%(5/11),P<0.05. Conclusion As adjunct to chemotherapy,Mycobacterium vaccae vaccine is helpful for patients with lung cancer and malignant pleural effusion.

Key words: Mycobacterium vaccae, Pleural effusion, Lung cancer, Immunotherapy